Hikma Eyes Return To Growth After Further Cutting Generics Forecasts
Injectables And Branded Increases Offset 18% Sales Slide For Generics Unit In First Half
• By David Wallace
Hikma sees light at the end of the tunnel for its generics business • Source: Shutterstock 
